BSE filing, NSE: INDOEURO. Summary written from the filing by ALFA Finder's alert engine.
Indo Euro Indchem Ltd: key numbers
- Share price
- ₹8.00
- Market cap
- ₹7.24 Cr
- Revenue (annual)
- ₹13.73 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- 26.4×Sector 43.1×
- Promoter holding
- 56.24%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo Euro Indchem Ltd
All →Indo Euro Indchem Board Meeting Date
Indo Euro Indchem will hold a board meeting on 3 November 2026 to consider unaudited standalone results for September 2026. Trading window remains closed until 5 November.
Indo Euro Indchem Other Announcement
The company filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
Indo Euro Indchem Annual General Meeting
Indo Euro Indchem held its 36th Annual General Meeting on September 29, 2026. Shareholders approved financial statements and new director appointments.
Indo Euro Indchem Annual Report
Indo Euro Indchem Ltd has filed its Annual Report for the financial year 2025-2026, which includes the notice for the 36th Annual General Meeting.
Indo Euro Indchem Annual General Meeting
Indo Euro Indchem Limited has scheduled its 36th Annual General Meeting for September 29, 2026, and released the Annual Report for the financial year 2025-26.
Indo Euro Indchem Management Change
Indo Euro Indchem Ltd has appointed Paresh Shah as a Whole-time Director, while Akshit Lakhani has resigned from the same position.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.